The United States Patent and Trademark Office (USPTO) has recorded an Intent to Use trademark application (TM99492714) for the mark 'INVIVOCAR'. The application, filed on November 12, 2025, pertains to pharmaceutical preparations intended for the treatment of cancer, autoimmune diseases, and infectious diseases. This filing signifies the applicant's intent to use the mark in commerce for these specified goods.

This is a trademark filing and does not impose new regulatory obligations on pharmaceutical companies. However, companies operating in the pharmaceutical sector should be aware of this application as it relates to potential brand protection and market exclusivity for cancer, autoimmune, and infectious disease treatments. No immediate compliance actions are required based on this notice.